1 Taddio et al, CMAJ 2005; 172(13) 1691-1695
2 LMX4 Summary of Product Characteristics
3 O’Brien et al, Pediatrics 2004; 114; e720 – e724
4 Koh et al, Pediatric Anesthesia 2004, 14; 977-98
5 Nestor, Journal of Drugs in Dermatology, Jul/Aug 2006, vol 5, issue 7
6 Mezei, Drug Permeation Enhancement, 1994, 171-98
7 MHRA LMX4 Lidocaine 4% w/w cream UK PAR
8 Kleiber et al, Pediatrics vol 100, No 4, October 2002
9 Taddio et al, The Annals of Pharmacology, 2002 April, vol 36
10 Emla Summary of Product Characteristics
11 Ametop Summary of Product Characteristics